Moberg Pharma AB (publ) (MOB) — Cash Flow-to-Debt Ratio
Moberg Pharma AB (publ) (MOB) has a Cash Flow-to-Debt Ratio of 0.09x as of December 2025, meaning its operating cash flow of Skr1.52 Million could theoretically repay 0% of its total liabilities (Skr17.04 Million) in one year. Explore how much of Moberg Pharma AB (publ)'s assets are long-term investments to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Moberg Pharma AB (publ) Cash Flow-to-Debt Ratio (2008–2025)
Historical debt coverage capacity for Moberg Pharma AB (publ) across 18 annual periods. Also explore total assets of Moberg Pharma AB (publ) for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Moberg Pharma AB (publ) (2008–2025)
Year-by-year debt coverage analysis for Moberg Pharma AB (publ). For market capitalisation and broader financial context, see Moberg Pharma AB (publ) stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.03x | Skr-17.49 Million | Skr17.04 Million | ▼ -20.0% |
| 2024 | -0.85x | Skr-16.47 Million | Skr19.27 Million | ▲ +38.2% |
| 2023 | -1.38x | Skr-33.20 Million | Skr24.01 Million | ▼ -153.3% |
| 2022 | -0.55x | Skr-16.84 Million | Skr30.84 Million | ▲ +39.9% |
| 2021 | -0.91x | Skr-15.30 Million | Skr16.84 Million | ▼ -158.0% |
| 2020 | -0.35x | Skr-29.93 Million | Skr85.00 Million | ▼ -321.9% |
| 2019 | 0.16x | Skr3.95 Million | Skr24.91 Million | ▲ +41.2% |
| 2018 | 0.11x | Skr73.89 Million | Skr657.60 Million | ▲ +40.1% |
| 2017 | 0.08x | Skr53.82 Million | Skr670.85 Million | ▲ +399.8% |
| 2016 | -0.03x | Skr-17.94 Million | Skr670.55 Million | ▼ -103.9% |
| 2015 | 0.69x | Skr30.72 Million | Skr44.63 Million | ▲ +138.4% |
| 2014 | 0.29x | Skr16.16 Million | Skr55.97 Million | ▲ +742.7% |
| 2013 | -0.04x | Skr-3.15 Million | Skr70.11 Million | ▼ -148.6% |
| 2012 | 0.09x | Skr9.48 Million | Skr102.53 Million | ▲ +116.1% |
| 2011 | -0.58x | Skr-9.02 Million | Skr15.67 Million | ▲ +77.9% |
| 2010 | -2.60x | Skr-30.41 Million | Skr11.69 Million | ▲ +47.6% |
| 2009 | -4.96x | Skr-25.26 Million | Skr5.09 Million | ▼ -4.7% |
| 2008 | -4.74x | Skr-34.89 Million | Skr7.36 Million | — |